HomeCompareAVB vs ALGN

AVB vs ALGN: Dividend Comparison 2026

AVB yields 4.33% · ALGN yields 1.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVB wins by $12.4K in total portfolio value
10 years
AVB
AVB
● Live price
4.33%
Share price
$161.56
Annual div
$7.00
5Y div CAGR
11.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.8K
Annual income
$2,127.22
Full AVB calculator →
ALGN
ALGN
● Live price
1.20%
Share price
$166.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$130.06
Full ALGN calculator →

Portfolio growth — AVB vs ALGN

📍 AVB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVBALGN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVB + ALGN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVB pays
ALGN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVB
Annual income on $10K today (after 15% tax)
$368.28/yr
After 10yr DRIP, annual income (after tax)
$1,808.14/yr
ALGN
Annual income on $10K today (after 15% tax)
$102.25/yr
After 10yr DRIP, annual income (after tax)
$110.55/yr
At 15% tax rate, AVB beats the other by $1,697.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVB + ALGN for your $10,000?

AVB: 50%ALGN: 50%
100% ALGN50/50100% AVB
Portfolio after 10yr
$27.6K
Annual income
$1,128.64/yr
Blended yield
4.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALGN right now

AVB
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$192.70
+19.3% upside vs current
Range: $172.00 — $217.00
Altman Z
1.6
Piotroski
7/9
ALGN
Analyst Ratings
24
Buy
7
Hold
2
Sell
Consensus: Buy
Price Target
$197.30
+18.7% upside vs current
Range: $140.00 — $220.00
Altman Z
4.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVB buys
0
ALGN buys
0
No recent congressional trades found for AVB or ALGN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVBALGN
Forward yield4.33%1.20%
Annual dividend / share$7.00$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR11.8%0%
Portfolio after 10y$33.8K$21.4K
Annual income after 10y$2,127.22$130.06
Total dividends collected$11.2K$1.3K
Payment frequencyquarterlyquarterly
SectorREITStock
Analyst consensusHoldBuy
Analyst price target$192.70$197.30

Year-by-year: AVB vs ALGN ($10,000, DRIP)

YearAVB PortfolioAVB Income/yrALGN PortfolioALGN Income/yrGap
1← crossover$11,184$484.40$10,820$120.29+$364.00AVB
2$12,533$566.08$11,699$121.65+$834.00AVB
3$14,074$662.81$12,641$122.92+$1.4KAVB
4$15,836$777.65$13,650$124.13+$2.2KAVB
5$17,859$914.31$14,731$125.27+$3.1KAVB
6$20,187$1,077.35$15,889$126.34+$4.3KAVB
7$22,872$1,272.39$17,128$127.36+$5.7KAVB
8$25,980$1,506.33$18,455$128.31+$7.5KAVB
9$29,586$1,787.73$19,876$129.21+$9.7KAVB
10$33,784$2,127.22$21,398$130.06+$12.4KAVB

AVB vs ALGN: Complete Analysis 2026

AVBREIT

As of December 31, 2020, the Company owned or held a direct or indirect ownership interest in 291 apartment communities containing 86,025 apartment homes in 11 states and the District of Columbia, of which 18 communities were under development and one community was under redevelopment. The Company is an equity REIT in the business of developing, redeveloping, acquiring and managing apartment communities in leading metropolitan areas in New England, the New York/New Jersey Metro area, the Mid-Atlantic, the Pacific Northwest, and Northern and Southern California, as well as in the Company's expansion markets consisting of Southeast Florida and Denver, Colorado (the Expansion Markets).

Full AVB Calculator →

ALGNStock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Full ALGN Calculator →
📬

Get this AVB vs ALGN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVB vs SCHDAVB vs JEPIAVB vs OAVB vs KOAVB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.